About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 845618, 10 pages
http://dx.doi.org/10.1155/2012/845618
Review Article

Classic and New Animal Models of Parkinson's Disease

1Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA
2Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA
3Department of Neurology, Columbia University, New York, NY 10032, USA

Received 9 January 2012; Accepted 23 January 2012

Academic Editor: Monica Fedele

Copyright © 2012 Javier Blesa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [134 citations]

The following is the list of published articles that have cited the current article.

  • Kurt A. Jellinger, “Potential role of α-synuclein in neurodegeneration: studies in a rat animal model,” Journal of Neurochemistry, vol. 122, no. 4, pp. 659–660, 2012. View at Publisher · View at Google Scholar
  • Quinton R.D. Jones, Jordan Warford, H.P. Vasantha Rupasinghe, and George S. Robertson, “Target-based selection of flavonoids for neurodegenerative disorders,” Trends in Pharmacological Sciences, vol. 33, no. 11, pp. 602–610, 2012. View at Publisher · View at Google Scholar
  • P. Rojas, E. Ruiz-Sánchez, C. Rojas, and S.O. Ögren, “Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice,” Neuroscience, vol. 223, pp. 246–257, 2012. View at Publisher · View at Google Scholar
  • Isabelle St-Amour, Melanie Bousquet, Isabelle Pare, Janelle Drouin-Ouellet, Francesca Cicchetti, Renee Bazin, and Frederic Calon, “Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease,” Journal Of Neuroinflammation, vol. 9, 2012. View at Publisher · View at Google Scholar
  • Andrea L. Nuckolls, Cole Worley, Christopher Leto, Hongyu Zhang, Jill K. Morris, and John A. Stanford, “Tongue force and tongue motility are differently affected by unilateral vs bilateral nigrostriatal dopamine depletion in rats,” Behavioural Brain Research, vol. 234, no. 2, pp. 343–348, 2012. View at Publisher · View at Google Scholar
  • Puneet Bagga, Anup N. Chugani, Komanduri S. Varadarajan, and Anant B. Patel, “ In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment ,” Journal of Neurochemistry, 2013. View at Publisher · View at Google Scholar
  • Maria Galuppo, Renato Iori, Gina Rosalinda De Nicola, Placido Bramanti, and Emanuela Mazzon, “Anti-inflammatory and anti-apoptotic effects of (R-s)-glucoraphanin bioactivated with myrosinase in murine sub-acute and acute MPTP-induced Parkinson's disease,” Bioorganic & Medicinal Chemistry, vol. 21, no. 17, pp. 5532–5547, 2013. View at Publisher · View at Google Scholar
  • Md Shahaduzzaman, Sandra Acosta, Paula C. Bickford, and Cesar V. Borlongan, “α-Synuclein is a pathological link and therapeutic target for Parkinson’s disease and traumatic brain injury,” Medical Hypotheses, 2013. View at Publisher · View at Google Scholar
  • Ana Clara Cristóvão, Joana Barata, Goun Je, and Yoon-Seong Kim, “PKCδ mediates paraquat-induced Nox1 expression in dopaminergic neurons,” Biochemical and Biophysical Research Communications, 2013. View at Publisher · View at Google Scholar
  • Adrianna Z. Herskovits, and Leonard Guarente, “Sirtuin deacetylases in neurodegenerative diseases of aging,” Cell Research, vol. 23, no. 6, pp. 746–758, 2013. View at Publisher · View at Google Scholar
  • Paul McGonigle, “Animal Models of CNS Disorders,” Biochemical Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Kai-Li Ma, Jia-Hong Gao, Zhang-Qiong Huang, Ying Zhang, De-Xuan Kuang, Qin-Fang Jiang, Yuan-Yuan Han, Cong Li, Wen-Guang Wang, Xiao-Yan Huang, Juan Xu, Pin-Fen Tong, Xing-Xiao Yin, and Jie-Jie Dai, “Motor Function in MPTP-Treated Tree Shrews (Tupaia belangeri chinensis),” Neurochemical Research, 2013. View at Publisher · View at Google Scholar
  • Marina Spanos, Julie Gras-Najjar, Jeremy M. Letchworth, Audrey L. Sanford, J. Vincent Toups, and Leslie A. Sombers, “Quantitation of Hydrogen Peroxide Fluctuations and Their Modulation of Dopamine Dynamics in the Rat Dorsal Striatum Using Fast-Scan Cyclic Voltammetry,” ACS Chemical Neuroscience, vol. 4, no. 5, pp. 782–789, 2013. View at Publisher · View at Google Scholar
  • Cheong-Meng Chong, Zhong-Yan Zhou, Valentina Razmovski-Naumovski, Guo-Zhen Cui, Lun-Qing Zhang, Fei Sa, Pui-Man Hoi, Kelvin Chan, and Simon Ming-Yuen Lee, “Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish,” Neuroscience Letters, vol. 543, pp. 121–125, 2013. View at Publisher · View at Google Scholar
  • Hugo Gonzalez, Francisco Contreras, Carolina Prado, Daniela Elgueta, Dafne Franz, Sebastian Bernales, and Rodrigo Pacheco, “Dopamine Receptor D3 Expressed on CD4(+) T Cells Favors Neurodegeneration of Dopaminergic Neurons during Parkinson's Disease,” Journal Of Immunology, vol. 190, no. 10, pp. 5048–5056, 2013. View at Publisher · View at Google Scholar
  • Marcio Lazzarini, Sabine Martin, Mišo Mitkovski, Rita Raisman Vozari, Walter Stühmer, and Elaine Del Bel, “Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model,” Glia, 2013. View at Publisher · View at Google Scholar
  • Pádraig Mulcahy, Aideen O’Doherty, Alexia Paucard, Timothy O’Brien, Deniz Kirik, and Eilís Dowd, “The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats,” Behavioural Brain Research, vol. 243, pp. 6–15, 2013. View at Publisher · View at Google Scholar
  • Massimo S. Fiandaca, and Howard J. Federoff, “Using viral-mediated gene delivery to model Parkinson's disease: Do nonhuman primate investigations expand our understanding?,” Experimental Neurology, 2013. View at Publisher · View at Google Scholar
  • David T. Dexter, and Peter Jenner, “Parkinson disease: from pathology to molecular disease mechanisms,” Free Radical Biology and Medicine, 2013. View at Publisher · View at Google Scholar
  • Sudipta Chakraborty, Julia Bornhorst, Thuy T. Nguyen, and Michael Aschner, “Oxidative Stress Mechanisms Underlying Parkinson's Disease-Associated Neurodegeneration in C. elegans,” International Journal of Molecular Sciences, vol. 14, no. 11, pp. 23103–23128, 2013. View at Publisher · View at Google Scholar
  • Kaitlin F. Farrell, Sesha Krishnamachari, Ernesto Villanueva, Haiyan Lou, Tshianda N. M. Alerte, Eloise Peet, Robert E. Drolet, and Ruth G. Perez, “Non-motor parkinsonian pathology in aging A53T α-Synuclein mice is associated with progressive synucleinopathy and altered enzymatic function,” Journal of Neurochemistry, 2013. View at Publisher · View at Google Scholar
  • Joana Guimaraes, Eduardo Moura, Elisabete Silva, Paulo Aguiar, Carolina Garrett, and Maria Augusta Vieira-Coelho, “Locus Coeruleus Is Involved in Weight Loss in a Rat Model of Parkinson's Disease: An Effect Reversed by Deep Brain Stimulation,” Brain Stimulation, vol. 6, no. 6, pp. 845–855, 2013. View at Publisher · View at Google Scholar
  • Honglei Chen, Edward A. Burton, G. Webster Ross, Xuemei Huang, Rodolfo Savica, Robert D. Abbott, Alberto Ascherio, John N. Caviness, Xiang Gao, Kimberly A. Gray, Jau-Shyong Hong, Freya Kamel, Danna Jennings, Annette Kirshner, Cindy Lawler, Rui Liu, Gary W. Miller, Robert Nussbaum, Shyamal D. Peddada, Amy Comstock Rick, Beate Ritz, Andrew D. Siderowf, Caroline M. Tanner, Alexander I. Troester, and Jing Zhang, “Research on the Premotor Symptoms of Parkinson's Disease: Clinical and Etiological Implications,” Environmental Health Perspectives, vol. 121, no. 11-12, pp. 1245–1252, 2013. View at Publisher · View at Google Scholar
  • Neeta D. Grover, Ramachandra P. Limaye, Dilip V. Gokhale, and Tatyasaheb R. Patil, “Zonisamide: A review of the clinical and experimental evidence for its use in Parkinson's disease,” Indian Journal of Pharmacology, vol. 45, no. 6, pp. 547–555, 2013. View at Publisher · View at Google Scholar
  • Gabriela P. Chaves-Kirsten, Caio H. Y. Mazucanti, Caroline C. Real, Bruna M. Souza, Luiz R. G. Britto, and Andrea S. Torrao, “Temporal Changes of CB1 Cannabinoid Receptor in the Basal Ganglia as a Possible Structure-Specific Plasticity Process in 6-OHDA Lesioned Rats,” Plos One, vol. 8, no. 10, 2013. View at Publisher · View at Google Scholar
  • Sachi Tanaka, Maki Nishimura, Fumiaki Ihara, Junya Yamagishi, and Yutaka Suzuki, “Transcriptome Analysis of Mouse Brain Infected with Toxoplasma gondii,” Infection and Immunity, vol. 81, no. 10, pp. 3609–3619, 2013. View at Publisher · View at Google Scholar
  • Xin Zhao, Shenyu Zhai, Ming-Sheng An, Yue-Hua Wang, Ying-Fan Yang, Hui-Qi Ge, Jin-Hao Liu, and Xiao-Ping Pu, “Neuroprotective Effects of Protocatechuic Aldehyde against Neurotoxin-Induced Cellular and Animal Models of Parkinson's Disease,” Plos One, vol. 8, no. 10, 2013. View at Publisher · View at Google Scholar
  • Salvatore Condello, Monica Currò, Nadia Ferlazzo, Gregorio Costa, Giuseppa Visalli, Daniela Caccamo, Laura Rosa Pisani, Cinzia Costa, Paolo Calabresi, Riccardo Ientile, and Francesco Pisani, “Protective Effects of Zonisamide Against Rotenone-Induced Neurotoxicity,” Neurochemical Research, 2013. View at Publisher · View at Google Scholar
  • Mohammed Gebriel, Shubhangi Prabhudesai, Kai-Erik Uleberg, Eivind Larssen, Dominik Piston, Anne Hjelle Bjørnstad, and Simon Geir Møller, “Zebrafish brain proteomics reveals central proteins involved in neurodegeneration,” Journal of Neuroscience Research, 2013. View at Publisher · View at Google Scholar
  • Huaxin Sheng, Raphael E. Chaparro, Toshihiro Sasaki, Miwa Izutsu, Robert D. Pearlstein, Artak Tovmasyan, and David S. Warner, “Metalloporphyrins as Therapeutic Catalytic Oxidoreductants in Central Nervous System Disorders,” Antioxidants & Redox Signaling, pp. 131001093903006, 2013. View at Publisher · View at Google Scholar
  • Thomas Taetzsch, and Michelle L. Block, “Pesticides, Microglial NOX2, and Parkinson's Disease,” Journal of Biochemical and Molecular Toxicology, vol. 27, no. 2, pp. 137–149, 2013. View at Publisher · View at Google Scholar
  • Xian-Ming Luo, Hai Lin, Wei Wang, Marilyn S. Geaney, Lee Law, Shaun Wynyard, Shamim B. Shaikh, Henry Waldvogel, Richard L. M. Faull, Robert B. Elliott, Stephen J. M. Skinner, Jacqueline E. Lee, and Paul L. -J. Tan, “Recovery of Neurological Functions in Non-Human Primate Model of Parkinson's Disease by Transplantation of Encapsulated Neonatal Porcine Choroid Plexus Cells,” Journal of Parkinsons Disease, vol. 3, no. 3, pp. 275–291, 2013. View at Publisher · View at Google Scholar
  • Sandeep Vasant More, Hemant Kumar, In-Su Kim, Sushruta Koppulla, Byung-Wook Kim, and Dong-Kug Choi, “Strategic selection of neuroinflammatory models in parkinson's disease:Evidence from experimental studies,” CNS and Neurological Disorders - Drug Targets, vol. 12, no. 5, pp. 680–697, 2013. View at Publisher · View at Google Scholar
  • Yong Sung Kim, “Accumulation of Alpha-synuclein Causes Colonic Dysmotility Independently of Enteric Nervous Damage in the Early Stage of Parkinson's Disease (Neurogastroenterol Motil 2012;24:e425-e436),” Journal of Neurogastroenterology and Motility, vol. 19, no. 2, pp. 264, 2013. View at Publisher · View at Google Scholar
  • Alazne Domínguez, Antonia Álvarez, Enrique Hilario, Blanca Suarez-Merino, and Felipe Goñi-de-Cerio, “Central nervous system diseases and the role of the blood-brain barrier in their treatment,” Neuroscience Discovery, vol. 1, no. 1, pp. 3, 2013. View at Publisher · View at Google Scholar
  • Maja Puchades, Carl Johan Sogn, Jan Maehlen, Linda H. Bergersen, and Vidar Gundersen, “Unaltered lactate and glucose transporter levels in the MPTP mouse model of Parkinson's disease,” Journal of Parkinsons Disease, vol. 3, no. 3, pp. 371–385, 2013. View at Publisher · View at Google Scholar
  • Magdalena Kauczynska Karlsson, Praveen Sharma, Jan Aasly, Mathias Toft, Orjan Skogar, Solve Saebo, and Anders Lonneborg, “Found in transcription: Accurate Parkinson's disease classification in peripheral blood,” Journal of Parkinsons Disease, vol. 3, no. 1, pp. 19–29, 2013. View at Publisher · View at Google Scholar
  • Hyung-Mun Yun, Dong Young Choi, Ki Wan Oh, and Jin Tae Hong, “PRDX6 Exacerbates Dopaminergic Neurodegeneration in a MPTP Mouse Model of Parkinson’s Disease,” Molecular Neurobiology, 2014. View at Publisher · View at Google Scholar
  • Rosa Canet-Aviles, Geoffrey P. Lomax, Ellen G. Feigal, and Catherine Priest, “Proceedings: Cell Therapies for Parkinson's Disease From Discovery to Clinic,” Stem Cells Translational Medicine, vol. 3, no. 9, pp. 979–991, 2014. View at Publisher · View at Google Scholar
  • Taku Amo, Shinji Saiki, Tadashi Sawayama, Shigeto Sato, and Nobutaka Hattori, “Detailed analysis of mitochondrial respiratory chain defects caused by loss of PINK1,” Neuroscience Letters, 2014. View at Publisher · View at Google Scholar
  • Sergey V Anisimov, and Gesine Paul, “Transplantation of mesenchymal stem cells: a future therapy for Parkinson’s disease?,” Future Neurology, vol. 9, no. 4, pp. 475–486, 2014. View at Publisher · View at Google Scholar
  • Werner J Geldenhuys, Samir M Abdelmagid, Patrick J Gallegos, and Fayez F Safadi, “Parkinson’s disease biomarker: a patent evaluation of WO2013153386,” Expert Opinion on Therapeutic Patents, pp. 1–5, 2014. View at Publisher · View at Google Scholar
  • Raffaella Adami, Giuseppe Scesa, and Daniele Bottai, “Stem cell transplantation in neurological diseases: improving effectiveness in animal models,” Frontiers in Cell and Developmental Biology, vol. 2, 2014. View at Publisher · View at Google Scholar
  • Tiago Zaminelli, Raísa Wendhausen Gradowski, Taysa Bervian Bassani, Janaína Kohl Barbiero, Ronise M. Santiago, Daniele Maria-Ferreira, Cristiane Hatsuko Baggio, and Maria A. B. F. Vital, “Antidepressant and Antioxidative Effect of Ibuprofen in the Rotenone Model of Parkinson’s Disease,” Neurotoxicity Research, 2014. View at Publisher · View at Google Scholar
  • Dwayne Brown, Andrea Tamas, Dora Reglodi, and Yousef Tizabi, “PACAP Protects Against Inflammatory-Mediated Toxicity in Dopaminergic SH-SY5Y Cells: Implication for Parkinson’s Disease,” Neurotoxicity Research, 2014. View at Publisher · View at Google Scholar
  • Sandra Amor, Laura A. N. Peferoen, Daphne Y. S. Vogel, Marjolein Breur, Paul van der Valk, David Baker, and Johannes M. van Noort, “Inflammation in neurodegenerative diseases - an update,” Immunology, vol. 142, no. 2, pp. 151–166, 2014. View at Publisher · View at Google Scholar
  • Dasa Dolezalova, Marian Hruska-Plochan, Carsten R. Bjarkam, Jens Christian H. Sørensen, Miles Cunningham, David Weingarten, Joseph D. Ciacci, Stefan Juhas, Jana Juhasova, Jan Motlik, Michael P. Hefferan, Tom Hazel, Karl Johe, Cassiano Carromeu, Alysson Muotri, Jack Bui, Jan Strnadel, and Martin Marsala, “Pig models of neurodegenerative disorders: Utilization in cell replacement-based preclinical safety and efficacy studies,” Journal of Comparative Neurology, 2014. View at Publisher · View at Google Scholar
  • Un Ju Jung, Min-Tae Jeon, Myung-Sook Choi, and Sang Ryong Kim, “ Silibinin Attenuates MPP + -Induced Neurotoxicity in the Substantia Nigra In Vivo ,” Journal of Medicinal Food, pp. 140324090959009, 2014. View at Publisher · View at Google Scholar
  • Glenda E. Gillies, Ilse S. Pienaar, Shiv Vohra, and Zahi Qamhawi, “Sex Differences in Parkinson’s Disease,” Frontiers in Neuroendocrinology, 2014. View at Publisher · View at Google Scholar
  • Fengju Jia, Ning Song, Chenyang Zhao, Junxia Xie, and Hong Jiang, “Unexpected Improvements of Spatial Learning and Memory Abilities in Chronic Rotenone Intoxicated Mice,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • Dahmane Ouazia, Louis-Charles Levros, Éric Rassart, and Richard R. Desrosiers, “Dopamine down-regulation of protein L-isoaspartyl methyltransferase is dependent on reactive oxygen species in SH-SY5Y cells,” Neuroscience, 2014. View at Publisher · View at Google Scholar
  • Thomas Langer, “Dynamic survey of mitochondria by ubiquitin,” Embo Reports, vol. 15, no. 3, pp. 231–243, 2014. View at Publisher · View at Google Scholar
  • Elena A. Kozina, Gulnara R. Khakimova, Vitaly G. Khaindrava, Valeriayn G. Kucheryanu, Nadezhda E. Vorobyeva, Alexey N. Krasnov, Sophia G. Georgieva, Lidiya Kerkerian-Le Goff, and Michael V. Ugrumov, “Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of Mptp-treated mice at the presymptomatic and symptomatic stages of parkinsonism,” Journal of the Neurological Sciences, 2014. View at Publisher · View at Google Scholar
  • Maria Teresa Baltazar, Ricardo Jorge Dinis-Oliveira, Maria de Lourdes Bastos, Aristidis M. Tsatsakis, José Alberto Duarte, and Félix Carvalho, “Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases—A mechanistic approach,” Toxicology Letters, 2014. View at Publisher · View at Google Scholar
  • Leonard Guarente, “SIRT1 in Neurodevelopment and Brain Senescence,” Neuron, vol. 81, no. 3, pp. 471–483, 2014. View at Publisher · View at Google Scholar
  • Josiane W. Bortolotto, Giana P. Cognato, Raissa R. Christoff, Laura N. Roesler, Carlos E. Leite, Luiza W. Kist, Mauricio R. Bogo, Monica R. Vianna, and Carla D. Bonan, “ Long-Term Exposure to Paraquat Alters Behavioral Parameters and Dopamine Levels in Adult Zebrafish ( Danio Rerio ) ,” Zebrafish, pp. 140225122422005, 2014. View at Publisher · View at Google Scholar
  • Melissa Barker-Haliski, Daniel Friedman, H. Steve White, and Jacqueline A. French, “How Clinical Development Can, and Should, Inform Translational Science,” Neuron, vol. 84, no. 3, pp. 582–593, 2014. View at Publisher · View at Google Scholar
  • Florian Reinhart, Nabil El Massri, Fannie Darlot, Napoleon Torres, Daniel M Johnstone, Claude Chabrol, Thomas Costecalde, Jonathan Stone, John Mitrofanis, Alim-Louis Benabid, and Cécile Moro, “810nm near-infrared light offers neuroprotection and improves locomotor activity in MPTP-treated mice,” Neuroscience Research, 2014. View at Publisher · View at Google Scholar
  • Andrew L. Eagle, Oluyemi O. Olumolade, and Hajime Otani, “Partial dopaminergic denervation-induced impairment in stimulus discrimination acquisition in parkinsonian rats: A model for early Parkinson's disease,” Neuroscience Research, 2014. View at Publisher · View at Google Scholar
  • Jennifer N. Cremer, Katrin Amunts, Jochen Graw, Markus Piel, Frank Rösch, and Karl Zilles, “Neurotransmitter receptor density changes in Pitx3ak mice – a model relevant to Parkinson’s disease,” Neuroscience, 2014. View at Publisher · View at Google Scholar
  • Ulrika Nordström, Geneviève Beauvais, Anamitra Ghosh, Baby Chakrapani Pulikkaparambil Sasidharan, Martin Lundblad, Julia Fuchs, Rajiv L. Joshi, Jack W. Lipton, Andrew Roholt, Satish Medicetty, Timothy N. Feinstein, Jennifer A. Steiner, Martha L. Escobar Galvis, Alain Prochiantz, and Patrik Brundin, “Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease,” Neurobiology of Disease, 2014. View at Publisher · View at Google Scholar
  • Jenny Sandstroem von Tobela, Debora Zoiab, Jorane Althaus, Paola Antinori, Julien Mermoud, Hui Song Pak, Alexander Scherla, and Florianne Monnet-Tschudi, “Immediate and delayed effects of subchronic Paraquat exposure during an early differentiation stage in 3D-rat brain cell cultures,” Toxicology Letters, vol. 230, no. 2, pp. 188–197, 2014. View at Publisher · View at Google Scholar
  • Andrzej Dekundy, Flora Mela, Martine Hofmann, and Wojciech Danysz, “Effects of dopamine uptake inhibitor MRZ-9547 in animal models of Parkinson’s disease,” Journal of Neural Transmission, 2014. View at Publisher · View at Google Scholar
  • Alvaro Martin, Cosmin A. Tegla, Cornelia D. Cudrici, Adam M. Kruszewski, Philippe Azimzadeh, Dallas Boodhoo, Armugam P. Mekala, Violeta Rus, and Horea Rus, “Role of SIRT1 in autoimmune demyelination and neurodegeneration,” Immunologic Research, 2014. View at Publisher · View at Google Scholar
  • Oytun Erbaş, Bilge Piri Çınar, Volkan Solmaz, Türker Çavuşoğlu, and Utku Ateş, “The neuroprotective effect of erythropoietin on experimental Parkinson model in rats,” Neuropeptides, 2014. View at Publisher · View at Google Scholar
  • Pasan Fernando, Xuxu Yan, Julia Lockwood, Yin Duan, Lihui Wei, R. Glenn Wells, Corinne Bensimon, Wayne M. Mullett, and Terrence Ruddy, “Toxicological Evaluation of a Rotenone Derivative in Rodents for Clinical Myocardial Perfusion Imaging,” Cardiovascular Toxicology, 2014. View at Publisher · View at Google Scholar
  • T. R. Petrosyan, O. V. Gevorkyan, and A. S. Hovsepyan, “Effects of Bacterial Melanin on Movement, Posture, and Skilled Balancing Deficits After Unilateral Destruction of Substantia Nigra Pars Compacta in Rats,” Journal of Motor Behavior, vol. 46, no. 1, pp. 67–72, 2014. View at Publisher · View at Google Scholar
  • Alazne Dominguez, Blanca Suarez-Merino, and Felipe Goni-de-Cerio, “Nanoparticles and Blood-Brain Barrier: The Key to Central Nervous System Diseases,” Journal of Nanoscience and Nanotechnology, vol. 14, no. 1, pp. 766–779, 2014. View at Publisher · View at Google Scholar
  • Anne-Marie Arel-Dubeau, Fanny Longpré, Julie Bournival, Cindy Tremblay, Julie Demers-Lamarche, Pavlina Haskova, Everaldo Attard, Marc Germain, and Maria-Grazia Martinoli, “Cucurbitacin E Has Neuroprotective Properties and Autophagic Modulating Activities on Dopaminergic Neurons,” Oxidative Medicine and Cellular Longevity, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Slawomir Wojcik, Jan Henryk Spodnik, Edyta Spodnik, Jerzy Dziewiatkowski, and Janusz Morys, “Nigrostriatal pathway degeneration in rats after intraperitoneal administration of proteasome inhibitor MG-132,” Folia Neuropathologica, vol. 52, no. 1, pp. 41–55, 2014. View at Publisher · View at Google Scholar
  • Ramin Ansari, Ali Mahta, Eric Mallack, and Jin Jun Luo, “Hyperhomocysteinemia and Neurologic Disorders: a Review,” Journal of Clinical Neurology, vol. 10, no. 4, pp. 281, 2014. View at Publisher · View at Google Scholar
  • Fabrine Sales Massafera Tristão, Márcio Lazzarini, Sabine Martin, Majid Amar, Walter Stühmer, Frank Kirchhoff, Lucas Araújo Caldi Gomes, Laurance Lanfumey, Rui D. Prediger, Julia E. Sepulveda, Elaine A. Del-Bel, and Rita Raisman-Vozari, “CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration,” Neurotoxicity Research, 2015. View at Publisher · View at Google Scholar
  • Huan Li, Wooyoung Jang, Hee Ju Kim, Kwang Deog Jo, Moon Kyu Lee, Sun Hong Song, and Hyun Ok Yang, “Biochemical protective effect of 1,25-dihydroxyvitamin D3 through autophagy induction in the MPTP mouse model of Parkinson’s disease,” NeuroReport, vol. 26, no. 12, pp. 669–674, 2015. View at Publisher · View at Google Scholar
  • D. Hernandez-Baltazar, L.M. Zavala-Flores, and A. Villanueva-Olivo, “El modelo de 6-hidroxidopamina y la fisiopatología parkinsoniana: nuevos hallazgos en un viejo modelo,” Neurología, 2015. View at Publisher · View at Google Scholar
  • Hao Li, Xiaoguang Lei, Ting Yan, Hongwei Li, Baihui Huang, Ling Li, Liqi Xu, Li Liu, Nanhui Chen, Longbao Lü, Yuanye Ma, Lin Xu, Jiali Li, Zhengbo Wang, Baorong Zhang, and Xintian Hu, “The temporary and accumulated effects of transcranial direct current stimulation for the treatment of advanced Parkinson’s disease monkeys,” Scientific Reports, vol. 5, pp. 12178, 2015. View at Publisher · View at Google Scholar
  • Ewa Niedzielska, Irena Smaga, Maciej Gawlik, Andrzej Moniczewski, Piotr Stankowicz, Joanna Pera, and Małgorzata Filip, “Oxidative Stress in Neurodegenerative Diseases,” Molecular Neurobiology, 2015. View at Publisher · View at Google Scholar
  • Yan Liu, Jian-Dong Sun, Lian-Kun Song, Jing Li, Shi-Feng Chu, Yu-He Yuan, and Nai-Hong Chen, “Environment-contact Administration of Rotenone: A New Rodent Model of Parkinson's Disease,” Behavioural Brain Research, 2015. View at Publisher · View at Google Scholar
  • Jingzhong Zhang, Sebastian Götz, Daniela M. Vogt Weisenhorn, Antonio Simeone, Wolfgang Wurst, and Nilima Prakash, “A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1+/– mice,” Neurobiology of Disease, 2015. View at Publisher · View at Google Scholar
  • Begum Alural, Aysegul Ozerdem, Jens Allmer, Kursad Genc, and Sermin Genc, “Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells,” Frontiers in Cellular Neuroscience, vol. 9, 2015. View at Publisher · View at Google Scholar
  • Shira Rockowitz, and Deyou Zheng, “Significant expansion of the REST/NRSF cistrome in human versus mouse embryonic stem cells: potential implications for neural development,” Nucleic Acids Research, vol. 43, no. 12, pp. 5730–5743, 2015. View at Publisher · View at Google Scholar
  • Xiaoguang Lei, Hao Li, Baihui Huang, Joshua Rizak, Ling Li, Liqi Xu, Li Liu, Jing Wu, Longbao Lu, Zhengbo Wang, Yingzhou Hu, Weidong Le, Xingli Deng, Jiali Li, Yonggang Yao, Lin Xu, Xintian Hu, and Baorong Zhang, “1-Methyl-4-Phenylpyridinium Stereotactic Infusion Completely and Specifically Ablated the Nigrostriatal Dopaminergic Pathway in Rhesus Macaque,” Plos One, vol. 10, no. 5, 2015. View at Publisher · View at Google Scholar
  • Hyung-Wook Kim, Won-Seok Choi, Noah Sorscher, Hyung Joon Park, François Tronche, Richard D. Palmiter, and Zhengui Xia, “Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo,” Neurobiology of Aging, 2015. View at Publisher · View at Google Scholar
  • Tomasz Maciej Stępkowski, Iwona Wasyk, Agnieszka Grzelak, and Marcin Kruszewski, “6-OHDA-Induced Changes in Parkinson`s Disease-Related Gene Expression are not Affected by the Overexpression of PGAM5 in In Vitro Differentiated Embryonic Mesencephalic Cells,” Cellular and Molecular Neurobiology, 2015. View at Publisher · View at Google Scholar
  • Hao Li, Xiaoguang Lei, Baihui Huang, Joshua D. Rizak, Lichuan Yang, Shangchuan Yang, Jing Wu, Longbao Lü, Jianhong Wang, Ting Yan, Hongwei Li, Zhengbo Wang, Yingzhou Hu, Weidong Le, Xingli Deng, Jiali Li, Lin Xu, Baorong Zhang, and Xintian Hu, “A quantitative approach to developing Parkinsonian monkeys (Macaca fascicularis) with intracerebroventricular 1-methyl-4-phenylpyridinium injections,” Journal of Neuroscience Methods, 2015. View at Publisher · View at Google Scholar
  • Dorit Trudler, Yuval Nash, and Dan Frenkel, “New insights on Parkinson’s disease genes: the link between mitochondria impairment and neuroinflammation,” Journal of Neural Transmission, 2015. View at Publisher · View at Google Scholar
  • Anderson H.F.F. Leão, Aldair J. Sarmento-Silva, José R. Santos, Alessandra M. Ribeiro, and Regina H. Silva, “Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model,” Brain Pathology, 2015. View at Publisher · View at Google Scholar
  • Daniela Lecca, Daniel K. Nevin, Giovanna Mulas, Maria Antonietta Casu, Andrea Diana, Damiano Rossi, Gianni Sacchetti, and Anna R Carta, “Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice,” Neuroscience, 2015. View at Publisher · View at Google Scholar
  • Yupin Chen, Dong-qi Zhang, Zhong Liao, Bin Wang, Suzhen Gong, Chuang Wang, Ming-zi Zhang, Guo-hua Wang, Huaibin Cai, Francesca-Fang Liao, and Jiang-ping Xu, “Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson's disease,” Molecular Neurodegeneration, vol. 10, 2015. View at Publisher · View at Google Scholar
  • Adriana Galvan, Annaelle Devergnas, and Thomas Wichmann, “Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state,” Frontiers in Neuroanatomy, vol. 9, 2015. View at Publisher · View at Google Scholar
  • M. Zhou, G. Ottenberg, G. F. Sferrazza, C. Hubbs, M. Fallahi, G. Rumbaugh, A. F. Brantley, and C. I. Lasmezas, “Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment,” Brain, 2015. View at Publisher · View at Google Scholar
  • Akihiro Tsuchioka, Fumiki Oana, Takayuki Suzuki, Yuji Yamauchi, Tomoyuki Ijiro, Kouichi Kaidoh, and Masahiro Hiratochi, “Duration of drug action of dopamine D2 agonists in mice with 6-hydroxydopamine-induced lesions,” NeuroReport, vol. 26, no. 18, pp. 1126–1132, 2015. View at Publisher · View at Google Scholar
  • D. Caccamo, L. R. Pisani, P. Mazzocchetti, R. Ientile, P. Calabresi, F. Pisani, and C. Costa, “Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs,” Neurochemical Research, 2015. View at Publisher · View at Google Scholar
  • Florian Reinhart, Nabil El Massri, Claude Chabrol, Celine Cretallaz, Daniel M. Johnstone, Napoleon Torres, Fannie Darlot, Thomas Costecalde, Jonathan Stone, John Mitrofanis, Alim-Louis Benabid, and Cécile Moro, “Intracranial application of near-infrared light in a hemi-parkinsonian rat model: the impact on behavior and cell survival,” Journal of Neurosurgery, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Daniela Cornacchia, and Lorenz Studer, “Back and forth in time: Directing age in iPSC-derived lineages,” Brain Research, 2015. View at Publisher · View at Google Scholar
  • Ana B. Muñoz-Manchado, Javier Villadiego, Sonia Romo-Madero, Nela Suárez-Luna, Alfonso Bermejo-Navas, José A. Rodríguez-Gómez, Pablo Garrido-Gil, José L. Labandeira-García, Miriam Echevarría, José López-Barneo, and Juan J. Toledo-Aral, “Chronic and progressive Parkinson's disease MPTP model in adult and aged mice,” Journal of Neurochemistry, vol. 136, no. 2, pp. 373–387, 2015. View at Publisher · View at Google Scholar
  • Rodolphe Hajj, Aude Milet, Damien Toulorge, Nathalie Cholet, Julien Laffaire, Julie Foucquier, Sandra Robelet, Richard Mitry, Mickael Guedj, Serguei Nabirotchkin, Ilya Chumakov, and Daniel Cohen, “Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson’s disease,” Scientific Reports, vol. 5, pp. 16084, 2015. View at Publisher · View at Google Scholar
  • Carolina Pellegrini, Luca Antonioli, Rocchina Colucci, Vigilio Ballabeni, Elisabetta Barocelli, Nunzia Bernardini, Corrado Blandizzi, and Matteo Fornai, “Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence,” Parkinsonism & Related Disorders, 2015. View at Publisher · View at Google Scholar
  • A. Tinakoua, S. Bouabid, E. Faggiani, P. De Deurwaerdère, N. Lakhdar-Ghazal, and A. Benazzouz, “The impact of combined administration of paraquat and maneb on motor and non-motor functions in the rat,” Neuroscience, 2015. View at Publisher · View at Google Scholar
  • Felix Chan, Nichola Z. Lax, Ceri H. Davies, Douglass M. Turnbull, and Mark O. Cunningham, “Neuronal oscillations: a physiological correlate for targeting mitochondrial dysfunction in neurodegenerative diseases?,” Neuropharmacology, 2015. View at Publisher · View at Google Scholar
  • M. Ogata, K. Noda, H. Akita, and H. Ishibashi, “Characterization of nociceptive response to chemical, mechanical, and thermal stimuli in adolescent rats with neonatal dopamine depletion,” Neuroscience, 2015. View at Publisher · View at Google Scholar
  • Soham Mitra, Nilkanta Chakrabarti, Spandita Seouli Dutta, Sucharit Ray, Promita Bhattacharya, Priyobrata Sinha, and Arindam Bhattacharyya, “Gender Specific Brain Regional Variation of Neurons, Endogenous Estrogen, Neuroinflammation and Glial Cells During Rotenone Induced Mouse Model of Parkinson’s Disease,” Neuroscience, 2015. View at Publisher · View at Google Scholar
  • Eun-Jung Park, and John M. Pezzuto, “The Pharmacology of Resveratrol in Animals and Humans,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015. View at Publisher · View at Google Scholar
  • Shinichi Amano, Deborah Kegelmeyer, and S. Lee Hong, “Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits,” Frontiers in Systems Neuroscience, vol. 8, 2015. View at Publisher · View at Google Scholar
  • Kanathip Singsai, Tarinee Akaravichien, Veerapol Kukongviriyapan, and Jintana Sattayasai, “ Protective Effects of Streblus asper Leaf Extract on H 2 O 2 -Induced ROS in SK-N-SH Cells and MPTP-Induced Parkinson’s Disease-Like Symptoms in C57BL/6 Mouse ,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Ester Tellone, Antonio Galtieri, Annamaria Russo, Bruno Giardina, and Silvana Ficarra, “Resveratrol: A Focus on Several Neurodegenerative Diseases,” Oxidative Medicine and Cellular Longevity, vol. 2015, pp. 1–14, 2015. View at Publisher · View at Google Scholar
  • Shreesh Ojha, Hayate Javed, Sheikh Azimullah, Salema B. Abul Khair, and M. Emdadul Haque, “Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease,” Drug Design Development And Therapy, vol. 9, pp. 5499–5510, 2015. View at Publisher · View at Google Scholar
  • Sudipta Chakraborty, Pan Chen, Julia Bornhorst, Tanja Schwerdtle, Fabian Schumacher, Burkhard Kleuser, Aaron B. Bowman, and Michael Aschner, “Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C. elegans,” Metallomics, vol. 7, no. 5, pp. 847–856, 2015. View at Publisher · View at Google Scholar
  • Sandeep More, Hemant Kumar, Duk-Yeon Cho, Yo-Sep Yun, and Dong-Kug Choi, “Toxin-Induced Experimental Models of Learning and Memory Impairment,” International Journal of Molecular Sciences, vol. 17, no. 9, pp. 1447, 2016. View at Publisher · View at Google Scholar
  • Anja Drinkut, Karsten Tillack, Durga P Meka, Jorg B Schulz, Sebastian Kügler, and Edgar R Kramer, “Ret is essential to mediate GDNF’s neuroprotective and neuroregenerative effect in a Parkinson disease mouse model,” Cell Death and Disease, vol. 7, no. 9, pp. e2359, 2016. View at Publisher · View at Google Scholar
  • C. Pellegrini, R. Colucci, L. Antonioli, E. Barocelli, V. Ballabeni, N. Bernardini, C. Blandizzi, W. J. de Jonge, and M. Fornai, “Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models,” Neurogastroenterology & Motility, 2016. View at Publisher · View at Google Scholar
  • Elisa Garbayo, Eduardo Ansorena, Hugo Lana, María del Mar Carmona-Abellan, Irene Marcilla, José Luis Lanciego, María Rosario Luquin, and María José. Blanco-Prieto, “Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys,” Biomaterials, 2016. View at Publisher · View at Google Scholar
  • Melanie Tremblay, Mason M. Silveira, Sukhbir Kaur, Jay G. Hosking, Wendy K. Adams, Christelle Baunez, and Catharine A. Winstanley, “ Chronic D 2/3 agonist ropinirole treatment increases preference for uncertainty in rats regardless of baseline choice patterns ,” European Journal of Neuroscience, 2016. View at Publisher · View at Google Scholar
  • Chien Tai Hong, Kai-Yin Chau, and Anthony H. V. Schapira, “The Cytomegalovirus protein pUL37×1 targets mitochondria to mediate neuroprotection,” Scientific Reports, vol. 6, pp. 31373, 2016. View at Publisher · View at Google Scholar
  • Philippe De Deurwaerdère, Giuseppe Di Giovanni, and Mark J. Millan, “Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry,” Progress in Neurobiology, 2016. View at Publisher · View at Google Scholar
  • Marcos Roberto de Oliveira, Patrícia Fernanda Schuck, and Simone Morelo Dal Bosco, “Tanshinone I Induces Mitochondrial Protection through an Nrf2-Dependent Mechanism in Paraquat-TreatedHuman Neuroblastoma SH-SY5Y Cells,” Molecular Neurobiology, 2016. View at Publisher · View at Google Scholar
  • Xin Qi, Brandon Davis, Yung-Hsiao Chiang, Emily Filichia, Austin Barnett, Nigel H. Greig, Barry Hoffer, and Yu Luo, “Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model,” Journal of Neurochemistry, 2016. View at Publisher · View at Google Scholar
  • Isabel Lastres-Becker, Angel J. García-Yagüe, Robert H. Scannevin, María J. Casarejos, Sebastian Kügler, Alberto Rábano, and Antonio Cuadrado, “Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease,” Antioxidants & Redox Signaling, 2016. View at Publisher · View at Google Scholar
  • Adriana Sereniki, Cybelle F. B. Linard-Medeiros, Shirliane N. Silva, Juciene B. R. Silva, Tadeu J. S. Peixoto Sobrinho, Juliano R. da Silva, Lariza D. S. Alves, Soraya S. Smaili, Almir G. Wanderley, and Simone S. L. Lafayette, “Schinus terebinthifolius administration prevented behavioral and biochemical alterations in a rotenone model of Parkinson's disease,” Revista Brasileira De Farmacognosia-Brazilian Journal Of Pharmacognosy, vol. 26, no. 2, pp. 240–245, 2016. View at Publisher · View at Google Scholar
  • David Salat, Alastair J Noyce, Anette Schrag, and Eduardo Tolosa, “Challenges of modifying disease progression in prediagnostic Parkinson's disease,” The Lancet Neurology, 2016. View at Publisher · View at Google Scholar
  • Soham Mitra, Nabanita Ghosh, Priyobrata Sinha, Nilkanta Chakrabarti, and Arindam Bhattacharyya, “Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment,” Neuroscience Letters, vol. 616, pp. 86–92, 2016. View at Publisher · View at Google Scholar
  • Linlin Cong, Eric R. Muir, Cang Chen, Yusheng Qian, Jingwei Liu, K. C. Biju, Robert A. Clark, Senlin Li, and Timothy Q. Duong, “Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's Disease,” Plos One, vol. 11, no. 3, 2016. View at Publisher · View at Google Scholar
  • Scott D. Heinemann, Jessica M. Posimo, Daniel M. Mason, Daniel F. Hutchison, and Rehana K. Leak, “Synergistic stress exacerbation in hippocampal neurons: Evidence favoring the dual-hit hypothesis of neurodegeneration,” Hippocampus, 2016. View at Publisher · View at Google Scholar
  • Alon Simchovitz, Lilach Soreq, and Hermona Soreq, “Transcriptome profiling in Parkinson's leukocytes: from early diagnostics to neuroimmune therapeutic prospects,” Current Opinion in Pharmacology, vol. 26, pp. 102–109, 2016. View at Publisher · View at Google Scholar
  • Florian Reinhart, Nabil El Massri, Daniel M. Johnstone, Jonathan Stone, John Mitrofanis, Alim-Louis Benabid, and Cécile Moro, “Near-infrared light (670 nm) reduces MPTP-induced parkinsonism within a broad therapeutic time window,” Experimental Brain Research, 2016. View at Publisher · View at Google Scholar
  • Amit Khairnar, Jana Ruda-Kucerova, Eva Drazanova, Nikoletta Szabó, Peter Latta, Anas Arab, Birgit Hutter-Paier, Daniel Havas, Manfred Windisch, Alexandra Sulcova, Zenon Starcuk, András Király, and Irena Rektorova, “Late-stage α-synuclein accumulation in TNWT-61 mouse model of Parkinson's disease detected by diffusion kurtosis imaging,” Journal of Neurochemistry, vol. 136, no. 6, pp. 1259–1269, 2016. View at Publisher · View at Google Scholar
  • Lei Xing, Maddie J. Venables, and Vance L. Trudeau, “Role of aromatase and radial glial cells in neurotoxin-induced dopamine neuron degeneration and regeneration,” General and Comparative Endocrinology, 2016. View at Publisher · View at Google Scholar
  • Daniel M. Johnstone, Cecile Moro, Jonathan Stone, Alim-Louis Benabid, and John Mitrofanis, “Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease,” Frontiers In Neuroscience, vol. 9, 2016. View at Publisher · View at Google Scholar
  • Daniel M. Johnstone, Cécile Moro, Jonathan Stone, Alim-Louis Benabid, and John Mitrofanis, “Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease,” Frontiers in Neuroscience, vol. 9, 2016. View at Publisher · View at Google Scholar
  • Senthilkumar S. Karuppagounder, Yulan Xiong, Yunjong Lee, Maeve C. Lawless, Donghyun Kim, Emily Nordquist, Ian Martin, Preston Ge, Saurav Brahmachari, Aanishaa Jhaldiyal, Manoj Kumar, Shaida A. Andrabi, Ted M. Dawson, and Valina L. Dawson, “LRRK2 G2019S Transgenic Mice Display Increased Susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Mediated Neurotoxicity,” Journal of Chemical Neuroanatomy, 2016. View at Publisher · View at Google Scholar
  • Maria E. Figueiredo-Pereira, Chuhyon Corwin, and John Babich, “Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration,” Annals of the New York Academy of Sciences, 2016. View at Publisher · View at Google Scholar
  • Wenzhe Dong, Yan Zhou, and Zhifang Yang, “Research Progress of Mechanism of Action of Resveratrol,” Pharmacology & Pharmacy, vol. 07, no. 04, pp. 170–175, 2016. View at Publisher · View at Google Scholar
  • Wenzhe Dong, Yan Zhou, and Zhifang Yang, “Review on the Effect of Resveratrol on Central Nervous System Disease,” Journal of Behavioral and Brain Science, vol. 06, no. 03, pp. 118–123, 2016. View at Publisher · View at Google Scholar
  • Masami Ishido, and Eiko Shimaya, “Major histocompatibility complex expression in a rotenone model of Parkinson’s disease in rats,” Fundamental Toxicological Sciences, vol. 3, no. 3, pp. 101–108, 2016. View at Publisher · View at Google Scholar
  • Marty Hinz, Alvin Stein, Ted Cole, Beth McDougall, and Mark Westaway, “Parkinson's disease managing reversible neurodegeneration,” Neuropsychiatric Disease And Treatment, vol. 12, pp. 763–775, 2016. View at Publisher · View at Google Scholar